Clinical Trials

Please note: This new Sarcoma Centers Registry map and listing will replace our previous list of sarcoma centers. Access past content here. Over two dozen sarcoma centers have submitted details for the Sarcoma Centers Registry out of nearly 90 known centers. Additionally, several other centers are either in the process of submitting or are being actively encouraged to do so. While some sarcoma programs have been approved and listed, they have yet to complete the detailed program information required for the registry. During this transitional phase, we are committed to serving the sarcoma community by continuing to provide access to the previous SARC Centers list, which includes nearly 90 sarcoma centers. However, please note that this list will not feature the detailed program information that will be included in the broader Sarcoma Centers Registry. As we continue to build this new database we invite all sarcoma centers to apply and register.

The Sarcoma Centers Registry is a database of sarcoma institutions, centers, and practices worldwide. Centers can be filtered by pediatric and adult care and each center has a summary page with detailed information including useful telephone numbers.

All centers included in the Registry meet objective, qualifying criteria and share our commitment to sarcoma research through collaboration. Centers indicated as SARC Consortium Members have a collaborative research agreement with SARC. About consortium members.

August 31, 2021

SARC024

Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• …

Read more

January 15, 2021

New Study in Ewing Sarcoma Open to Enrollment

New Study in Ewing Sarcoma Open to Enrollment

SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination …

Read more

November 30, 2020

Open Accruing SARC Studies

Open Accruing SARC Studies

Open accruing studies for you to refer or enroll your patients: SARC024 for Rhabdomyosarcoma (alveolar and embryonal) and Mesenchymal Chondrosarcoma  SARC031 for Unresectable or Metastatic NF1 Associated or Sporadic Malignant Peripheral Nerve …

Read more

May 10, 2018

SARC009 PUBLISHED

JAMA Oncology Publication of SARC Study of Dasatinib Under the leadership of Dr. Scott Schuetze, Professor at the Rogel Cancer Center, Michigan Medicine, the results of the collaborative trial of …

Read more
Back to top